Indrajit GHOSH

Person

Hillsborough, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methyl...
- Patent number 10,131,639
- Issue date Nov 20, 2018
- Signal Pharmaceuticals, LLC
- Nathan Andrew Boersen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piper...
- Patent number 10,064,863
- Issue date Sep 4, 2018
- Celgene Corporation
- Colin Walters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methy...
- Patent number 9,796,685
- Issue date Oct 24, 2017
- Signal Pharmaceuticals, LLC
- Nathan Andrew Boersen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Oral formulations of deferasirox
- Patent number 9,283,209
- Issue date Mar 15, 2016
- Novartis AG
- Indrajit Ghosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...
- Publication number 20190031619
- Publication date Jan 31, 2019
- Signal Pharmaceuticals, LLC.
- Nathan Andrew BOERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORAL FORMULATIONS OF DEFERASIROX
- Publication number 20180221285
- Publication date Aug 9, 2018
- Novartis AG
- Indrajit Ghosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF DEFERASIROX
- Publication number 20180071220
- Publication date Mar 15, 2018
- INDRAJIT GHOSH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...
- Publication number 20180009765
- Publication date Jan 11, 2018
- Signal Pharmaceuticals, LLC.
- Nathan Andrew BOERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORAL FORMULATIONS OF DEFERASIROX
- Publication number 20170290811
- Publication date Oct 12, 2017
- Novartis AG
- Indrajit Ghosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPER...
- Publication number 20170056323
- Publication date Mar 2, 2017
- Celgene Corporation
- Colin Walters
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ORAL FORMULATIONS OF DEFERASIROX
- Publication number 20160220493
- Publication date Aug 4, 2016
- Novartis AG
- Indrajit Ghosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...
- Publication number 20160168105
- Publication date Jun 16, 2016
- Signal Pharmaceuticals, LLC.
- Nathan Andrew BOERSEN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ORAL FORMULATIONS OF DEFERASIROX
- Publication number 20150017241
- Publication date Jan 15, 2015
- Novartis AG
- Indrajit Ghosh
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Indrajit GHOSH

Person

Patents Grantslast 30 patents

Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methyl...

Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piper...

Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methy...

Oral formulations of deferasirox

Patents Applicationslast 30 patents

FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...

ORAL FORMULATIONS OF DEFERASIROX

ORAL FORMULATIONS OF DEFERASIROX

FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...

ORAL FORMULATIONS OF DEFERASIROX

FORMULATIONS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPER...

ORAL FORMULATIONS OF DEFERASIROX

FORMULATIONS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHY...

ORAL FORMULATIONS OF DEFERASIROX